# A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

> **NCT06915233** · PHASE3 · RECRUITING · sponsor: **Vericel Corporation** · enrollment: 309 (estimated)

## Conditions studied

- Chondral Defect
- Articular Cartilage Defect

## Interventions

- **BIOLOGICAL:** autologous cultured chondrocytes on porcine collagen membrane
- **PROCEDURE:** Bone Marrow Stimulation

## Key facts

- **NCT ID:** NCT06915233
- **Lead sponsor:** Vericel Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2030-07
- **Final completion:** 2030-07
- **Target enrollment:** 309 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06915233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06915233, "A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06915233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*